Coston McIsaac & Partners’s Bausch Health BHC Stock Holding History

Coston McIsaac & Partners’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	201	–	–	﹤0.01%	846
2026 Q1	$1K	Hold	201	–	–	﹤0.01%	782
2025 Q4	$1K	Sell	201 -23	-10%	-$151	﹤0.01%	776
2025 Q3	$1K	Hold	224	–	–	﹤0.01%	747
2025 Q2	$1K	Hold	224	–	–	﹤0.01%	721
2025 Q1	$1K	Hold	224	–	–	﹤0.01%	707
2024 Q4	$1K	Hold	224	–	–	﹤0.01%	707
2024 Q3	$1K	Hold	224	–	–	﹤0.01%	707
2024 Q2	$1K	Hold	224	–	–	﹤0.01%	687
2024 Q1	$2K	Hold	224	–	–	﹤0.01%	644
2023 Q4	$1K	Hold	224	–	–	﹤0.01%	672
2023 Q3	$1K	Hold	224	–	–	﹤0.01%	674
2023 Q2	$1K	Hold	224	–	–	﹤0.01%	717
2023 Q1	$1K	Hold	224	–	–	﹤0.01%	744
2022 Q4	$1K	Hold	224	–	–	﹤0.01%	714
2022 Q3	$1K	Hold	224	–	–	﹤0.01%	632
2022 Q2	$2K	Buy	+224	New	+$3.13K	﹤0.01%	413

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Coston McIsaac & Partners's BHC Position: Q2 2026 in Review

Coston McIsaac & Partners held its Bausch Health (BHC) position steady in Q2 2026 at 201 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #846.

Coston McIsaac & Partners first reported a position in BHC in Q2 2022 and has held it in 17 quarters since. The position peaked at $2K in Q1 2024. 221 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

Coston McIsaac & Partners held 201 shares of Bausch Health worth $0 as of Q2 2026.
Coston McIsaac & Partners left its Bausch Health share count unchanged in Q2 2026.
Bausch Health made up ﹤0.01% of Coston McIsaac & Partners's portfolio in Q2 2026, its #846 holding.
Coston McIsaac & Partners first reported a position in Bausch Health in Q2 2022 and has held it in 17 quarters since.
Coston McIsaac & Partners's Bausch Health position peaked at $2K in Q1 2024.
221 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.